Sales rise 3.24% to Rs 3090.38 crore
Net profit of Aurobindo Pharma declined 49.40% to Rs 380.95 crore in the quarter ended September 2018 as against Rs 752.83 crore during the previous quarter ended September 2017. Sales rose 3.24% to Rs 3090.38 crore in the quarter ended September 2018 as against Rs 2993.51 crore during the previous quarter ended September 2017. ParticularsQuarter EndedSep. 2018Sep. 2017% Var.Sales3090.382993.51 3 OPM %19.6434.72 -PBDT580.351056.05 -45 PBT479.41966.44 -50 NP380.95752.83 -49Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content